Delaware Street Capital Master Fund L.P. 13D and 13G filings for Zevra Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 07:01 am Purchase | 2020-12-31 | 13G | Zevra Therapeutics, Inc. ZVRA | Delaware Street Capital Master Fund L.P. | 159,364 3.400% | 159,364 (New Position) | Filing |